More Post from the Author
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
- ENERGIZER HOLDINGS, INC. DECLARES QUARTERLY DIVIDEND ON ITS COMMON STOCK
- KI-Wrmebildtechnik von Raytron setzt neue Mastbe fr die Vermeidung des thermischen Durchgehens von EV-Batterien
QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU
Published on Wed 12 Feb 2025 8:06:56 UTC
The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.
NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.
More Post from the Author
- r4 Technologies Donates Smart Food AI Program to Help States Feed SNAP Beneficiaries
- Armor Health's Data Driven Approach to Patient Care Helps Secure Agreement to Provide Correctional Healthcare Service for Inmates in Bell County Texas
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
- ENERGIZER HOLDINGS, INC. DECLARES QUARTERLY DIVIDEND ON ITS COMMON STOCK
- KI-Wrmebildtechnik von Raytron setzt neue Mastbe fr die Vermeidung des thermischen Durchgehens von EV-Batterien